Foreseeing the Moments of Occurrence of Everolimus Long-term Side Effects by Follow up of Trough Blood Concentrations
Phase of Trial: Phase IV
Latest Information Update: 05 Jun 2017
At a glance
- Drugs Everolimus (Primary)
- Indications Advanced breast cancer; Neuroendocrine tumours; Renal cell carcinoma
- Focus Adverse reactions
- Acronyms Foresight
- 31 Aug 2018 Biomarkers information updated
- 30 May 2017 Status changed from not yet recruiting to recruiting.
- 22 Mar 2017 Planned primary completion date changed from 1 Jul 2018 to 1 Sep 2018.